Supply Chain

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Kasey Kime, Xiao Peng

Innovator Insight

Streamlining the supply chain: insights on raw material sourcing and quality by design

Streamlining the supply chain: insights on raw material sourcing and quality by design

Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Laura Koivusalo, Anni Mörö, Ross Macdonald

Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells

Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells

Mark Kennedy, Marcus Bunn

Innovator Insight

Raw and starting materials for cellular and gene therapy products

Raw and starting materials for cellular and gene therapy products

Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy

Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy

Phil Morton, Shanya Jiang

Innovator Insight

Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors

Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors

J Hengst, Q Rafiq, R Ladi et al

27 February 2025

Innovator Insight

Investing in early-stage stem cell therapy developers

Investing in early-stage stem cell therapy developers

Stijn Heessen, Kristian Tryggvason

21 February 2025

Driving innovation in cell and gene therapy: the role of AI and robotics

Driving innovation in cell and gene therapy: the role of AI and robotics

Kenneth Harris, Mitchel Sivilotti, Anthony Rotunno

27 January 2025

1
2
3
4
5
6
7
8
9
10
...
>
>>

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

John Bowen, Brian Tomkowicz

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

Lili Belcastro, Basak Clements, Claire Wartel

Advancing AAV manufacturing: strategic insights and cost-effective solutions for the future of gene therapies

Advancing AAV manufacturing: strategic insights and cost-effective solutions for the future of gene therapies

Michael DiBiasio-White, Ying Cai, Roland Pach

06 February 2025

Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies

Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies

R Luke, M Giedlin, D Clarke et al

12 December 2024

When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

Amy Hines, Jeni Newman, Marcel van Houten

14 November 2024

Comparing activation methods to yield clinical-scale expansion of gamma delta T cells

Comparing activation methods to yield clinical-scale expansion of gamma delta T cells

Chengkang Zhang

24 September 2024

The benefits of single-use systems for enhanced process security

The benefits of single-use systems for enhanced process security

04 September 2024

Understanding and leveraging cord blood bank capabilities and practices in cell therapy development

Understanding and leveraging cord blood bank capabilities and practices in cell therapy development

J Aho, A Conerty, S Shields et al

Supporting efficacy and scaling with a next-generation T cell AOF formulation medium

Supporting efficacy and scaling with a next-generation T cell AOF formulation medium

Alan Gutowski, Joanna Kern

1
2
3
4
5
6
7
>
>>